Circulating Markers of Necroptosis in Acute Pancreatitis.

Autor: Belfrage H; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland. hanna.belfrage@hus.fi., Kuuliala K; Department of Bacteriology and Immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Kuuliala A; Department of Bacteriology and Immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Mustonen H; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland., Puolakkainen P; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland., Kylänpää L; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland., Louhimo J; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland.

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 2024 Sep; Vol. 69 (9), pp. 3333-3343. Date of Electronic Publication: 2024 Jun 28.

DLLabelsCT: Annotation tool using deep transfer learning to assist in creating new datasets from abdominal computed tomography scans, case study: Pancreas.

Autor: Mustonen H; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland., Isosalo A; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland., Nortunen M; Research Unit of Translational Medicine, Oulu University Hospital, Oulu, Finland.; Department of Surgery, Oulu University Hospital, Oulu, Finland., Nevalainen M; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.; Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland., Nieminen MT; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.; Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland., Huhta H; Research Unit of Translational Medicine, Oulu University Hospital, Oulu, Finland.; Department of Surgery, Oulu University Hospital, Oulu, Finland.

Publikováno v: PloS one [PLoS One] 2024 Dec 03; Vol. 19 (12), pp. e0313126. Date of Electronic Publication: 2024 Dec 03 (Print Publication: 2024).

Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Autor: Roos-Mattila M; Department of Surgery, Helsinki University Hospital, Helsinki, Finland. matilda.roos-mattila@helsinki.fi.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. matilda.roos-mattila@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. matilda.roos-mattila@helsinki.fi., Kallio P; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Luck TJ; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Polso M; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Kumari R; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Mikkonen P; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Välimäki K; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Malmstedt M; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ellonen P; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Pellinen T; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Heckman CA; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Mustonen H; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Puolakkainen PA; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Alitalo K; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Kallioniemi O; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland.; Science for Life Laboratory (SciLifeLab), Department of Oncology and Pathology, Karolinska Institutet, Solna, 17165, Sweden., Mirtti T; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Rannikko AS; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Pietiäinen VM; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Seppänen HE; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.

Publikováno v: Communications biology [Commun Biol] 2024 Oct 20; Vol. 7 (1), pp. 1355. Date of Electronic Publication: 2024 Oct 20.

Being creative is mandatory:experiences of communication in game development from the perspective of creative employees

Autor: Mustonen, H. (Heikki)

Although game development is a form of software development, it cannot be compared directly to traditional software development. The audio-visual elements of games and their fundamental requirement to be “fun” make them exceptionally challenging

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2423::5945dd5b98fa60d02b6d9bc769fbab45
http://jultika.oulu.fi/Record/nbnfioulu-202305121664

The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000-2016: a longitudinal nationwide cohort study.

Autor: Aaltonen P; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Mustonen H; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Peltola K; Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Carpén O; Medicum, Research Program in Systems Oncology and HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Puolakkainen P; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Haglund C; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Sund M; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Seppänen H; Department of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1732-1741. Date of Electronic Publication: 2023 Nov 25.